185 related articles for article (PubMed ID: 34042961)
1. Spliceosome-regulated RSRP1-dependent NF-κB activation promotes the glioblastoma mesenchymal phenotype.
Li Y; Wang X; Qi S; Gao L; Huang G; Ren Z; Li K; Peng Y; Yi G; Guo J; Yang R; Wang H; Zhang X; Liu Y
Neuro Oncol; 2021 Oct; 23(10):1693-1708. PubMed ID: 34042961
[TBL] [Abstract][Full Text] [Related]
2. lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma.
Tang G; Luo L; Zhang J; Zhai D; Huang D; Yin J; Zhou Q; Zhang Q; Zheng G
Cancer Lett; 2021 Feb; 498():152-164. PubMed ID: 33130316
[TBL] [Abstract][Full Text] [Related]
3. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
5. Silencing LncRNA LOXL1-AS1 attenuates mesenchymal characteristics of glioblastoma via NF-κB pathway.
Wang H; Li L; Yin L
Biochem Biophys Res Commun; 2018 Jun; 500(2):518-524. PubMed ID: 29678575
[TBL] [Abstract][Full Text] [Related]
6. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
[TBL] [Abstract][Full Text] [Related]
7. NF-κB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma.
McFarland BC; Hong SW; Rajbhandari R; Twitty GB; Gray GK; Yu H; Benveniste EN; Nozell SE
PLoS One; 2013; 8(11):e78728. PubMed ID: 24244348
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling.
Wang Z; Shi Y; Ying C; Jiang Y; Hu J
Oncogene; 2021 Feb; 40(8):1458-1475. PubMed ID: 33420370
[TBL] [Abstract][Full Text] [Related]
9. The positive regulatory loop of TCF4N/p65 promotes glioblastoma tumourigenesis and chemosensitivity.
Hu Y; Zhang B; Lu P; Wang J; Chen C; Yin Y; Wan Q; Wang J; Jiao J; Fang X; Pu Z; Gong L; Ji L; Zhu L; Zhang R; Zhang J; Yang X; Wang Q; Huang Z; Zou J
Clin Transl Med; 2022 Sep; 12(9):e1042. PubMed ID: 36116131
[TBL] [Abstract][Full Text] [Related]
10. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
[TBL] [Abstract][Full Text] [Related]
11. DNA damage-induced NF-κB activation in human glioblastoma cells promotes miR-181b expression and cell proliferation.
Xu RX; Liu RY; Wu CM; Zhao YS; Li Y; Yao YQ; Xu YH
Cell Physiol Biochem; 2015; 35(3):913-25. PubMed ID: 25633526
[TBL] [Abstract][Full Text] [Related]
12. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
13. Targeting NF-κB in glioblastoma: A therapeutic approach.
Friedmann-Morvinski D; Narasimamurthy R; Xia Y; Myskiw C; Soda Y; Verma IM
Sci Adv; 2016 Jan; 2(1):e1501292. PubMed ID: 26824076
[TBL] [Abstract][Full Text] [Related]
14. NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway.
Xiang J; Alafate W; Wu W; Wang Y; Li X; Xie W; Bai X; Li R; Wang M; Wang J
Cell Death Dis; 2022 Jan; 13(1):58. PubMed ID: 35031599
[TBL] [Abstract][Full Text] [Related]
15. Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype.
Raychaudhuri B; Han Y; Lu T; Vogelbaum MA
J Neurooncol; 2007 Oct; 85(1):39-47. PubMed ID: 17479228
[TBL] [Abstract][Full Text] [Related]
16. MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.
Yang G; Han D; Chen X; Zhang D; Wang L; Shi C; Zhang W; Li C; Chen X; Liu H; Zhang D; Kang J; Peng F; Liu Z; Qi J; Gao X; Ai J; Shi C; Zhao S
Neuro Oncol; 2014 May; 16(5):652-61. PubMed ID: 24463357
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma Mesenchymal Transition and Invasion are Dependent on a NF-κB/BRD2 Chromatin Complex.
Vadla R; Miki S; Taylor B; Kawauchi D; Jones BM; Nathwani N; Pham P; Tsang J; Nathanson DA; Furnari FB
bioRxiv; 2023 Jul; ():. PubMed ID: 37461511
[TBL] [Abstract][Full Text] [Related]
18. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.
Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S
Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445
[TBL] [Abstract][Full Text] [Related]
19. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma.
Atkinson GP; Nozell SE; Harrison DK; Stonecypher MS; Chen D; Benveniste EN
Oncogene; 2009 Oct; 28(42):3735-45. PubMed ID: 19668231
[TBL] [Abstract][Full Text] [Related]
20. The short isoform of MS4A7 is a novel player in glioblastoma microenvironment, M2 macrophage polarization, and tumor progression.
Ni B; Huang G; Yang R; Wang Z; Song H; Li K; Zhang Y; Wu K; Shi G; Wang X; Shen J; Liu Y
J Neuroinflammation; 2023 Mar; 20(1):80. PubMed ID: 36944954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
